CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 151 enrolled
Drug / intervention
Ingestible Sensor and Wearable Sensorother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02553512
NCT02553512N/ACompleted
CompareCT.gov

Helius in Hypertension-I: The UK Hypertension Registry

Proteus Digital Health, Inc.·observational·Posted Sep 17, 2015·Updated Jun 16, 2017

In Brief

An observational study evaluating Ingestible Sensor and Wearable Sensor for Essential Hypertension. Completed, enrolled 151 participants.

Detailed Summary

The purpose of this study is to demonstrate the use of a digital health offering in the management of persistent hypertension during chronic anti-hypertensive treatment.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsEssential Hypertension
Countries--
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedSep 17, 2015
Enrollment StartSep 1, 2013
Primary CompletionDec 1, 2014
Study CompletionMay 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 10.8 years ago

Interventions

Ingestible Sensor and Wearable Sensorother

This digital health offering passively acquires and records medication-taking and habits of daily living.